Phreesia, Inc.
NYSE:PHRMedical - Healthcare Information Services
+$0.08 today
- Market cap
- $760.99M
- Beta
- 0.88
- P/E (TTM)
- 62.6
- EPS (TTM)
- $0.15
Volume 0.86M
Average 1.97M
PHR Long-term Debt
Borrowings due after more than one year.
Phreesia, Inc.NYSE: PHR
Long-term Debt · Q1 FY2027 · quarter ended Apr 2026
Long-term debt rises 1284.3% from a year ago
Long-term debt stood at $85.3M at the end of Q1 FY2027, up 1284.3% from a year earlier and down 8.5% from the prior quarter. Over 3 fiscal years it compounded at +220.8% a year.
Context
- Long-term debt amounted to 12.8% of total assets at the end of Q1 FY2027, up 11.3 pp from a year earlier.
- Long-term debt increased in 1 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether long-term debt keeps rising in the next quarterly balance sheet after a +1284.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Long-term Debt history
USD · from the balance sheet
- Latest · FY2026
- 90M USD
- Year-over-year change
- +12417.4%
- 4-year CAGR
- +404.4%
| Period | Period end | Long-term Debt | YoY change |
|---|---|---|---|
| FY2026 | 2026-01-31 | 90M | +12417.4% |
| FY2025 | 2025-01-31 | 719K | -64.9% |
| FY2024 | 2024-01-31 | 2.05M | -24.8% |
| FY2023 | 2023-01-31 | 2.73M | +1860.4% |
| FY2022 | 2022-01-31 | 139K | — |
Long-term Debt vs competitors
How PHR compares with its peers on the latest reported figures
- PHR's Apr 2026 long-term debt of $85.3M is the 8th highest of the 11 companies compared; the peer median is $181.68M.
- Its year-over-year change of +1284.3% is the highest of 10, against a peer median of -0.7%.
- Long-term debt amounts to 12.8% of total assets for PHR, versus a peer median of 19.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $995.81M | +0.4% | -13.5% | 35.5% | |
| Aug 2026 | $774.2M | -2.3% | -3.6% | 23.4% | |
| Mar 2026 | $482.42M | -0.7% | -9.5% | 23.9% | |
| Sep 2026 | $267.82M | +8.7% | +12.2% | 74.6% | |
| Mar 2026 | $195.46M | +100.6% | -25.2% | 24.8% | |
| Mar 2026 | $167.9M | +0.7% | -33.4% | 8.4% | |
| Sep 2026 | $89.44M | — | — | 14.6% | |
| Apr 2026 | $85.3M | +1284.3% | +220.8% | 12.8% | |
| Jan 2026 | $42.26M | -3.4% | — | 11.1% | |
| Mar 2026 | $0 | -100.0% | — | 0.0% | |
| Mar 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding PHR) | $181.68M | -0.7% | -11.5% | 19.0% | |
Competitors are the stored peer set for PHR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Jan 2022 | FY2023 Jan 2023 | FY2024 Jan 2024 | FY2025 Jan 2025 | FY2026 Jan 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | 313.81M | 176.68M | 87.52M | 84.22M | 73.83M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 40.26M | 51.39M | 64.86M | 73.62M | 154.63M |
| Inventory | 1.64M | 1.06M | 768K | 0 | 0 |
| Other Current Assets | 21.74M | 25.94M | 32.48M | 34.13M | 51.39M |
| Total Current Assets | 386.35M | 262.44M | 195.68M | 203.29M | 279.84M |
| Property, Plant & Equipment (Net) | 36.98M | 22.24M | 17.17M | 25.13M | 23.59M |
| Goodwill | 33.62M | 33.74M | 75.85M | 75.85M | 170.06M |
| Intangible Assets | 30.42M | 46.55M | 77.76M | 80.91M | 79.76M |
| Long-term Investments | 2.44M | 0 | 0 | 0 | 0 |
| Tax Assets | 515K | 81K | 0 | 0 | 1.59M |
| Other Non-current Assets | 4.16M | 5.01M | 3.87M | 3.25M | 108.94M |
| Total Non-current Assets | 108.13M | 107.62M | 174.64M | 185.13M | 383.95M |
| Total Assets | 494.48M | 370.06M | 370.33M | 388.42M | 663.79M |
| Account Payables | 5.12M | 10.84M | 8.48M | 5.62M | 11.48M |
| Short-term Debt | 221K | 246K | 1.1M | 1.22M | 2.66M |
| Tax Payables | 2.09M | 1.49M | 3.04M | 2.5M | 0 |
| Deferred Revenue | 16.49M | 17.69M | 24.11M | 32.76M | 49.52M |
| Other Current Liabilities | 26.85M | 32.57M | 53.16M | 844K | 72.29M |
| Total Current Liabilities | 68.43M | 79.04M | 110.12M | 114.02M | 183.24M |
| Long-term Debt | 139K | 2.73M | 2.05M | 719K | 90M |
| Deferred Tax Liabilities | 2.71M | 1.35M | 270K | 484K | 4.5M |
| Deferred Revenue (Non-current) | 65K | 125K | 97K | 119K | 0 |
| Other Non-current Liabilities | (1) | (2.73M) | 2.86M | 185K | 45.62M |
| Total Non-current Liabilities | 8.76M | 3.2M | 8.76M | 9.58M | 143.34M |
| Total Liabilities | 77.2M | 82.24M | 118.88M | 123.61M | 326.58M |
| Common Stock | 521K | 542K | 577K | 601K | 620K |
| Retained Earnings | (429.94M) | (606.08M) | (742.97M) | (801.5M) | (799.19M) |
| Accumulated OCI | 0 | 0 | 0 | (51K) | (382K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 417.28M | 287.82M | 251.45M | 264.81M | 337.21M |
| Total Debt | 15.8M | 9.18M | 11.98M | 17.8M | 102.45M |
| Net Debt | (298.01M) | (167.5M) | (75.54M) | (66.42M) | 28.62M |
Phreesia, Inc.
NYSE:PHR
Intrinsic Alpha fair value
Locked
Current Price
$12.26
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.